The 49th Union World Conference
on Lung Health
Meet with Q2 Solutions at the 49th Union World Conference on Lung Health and explore how we can help you improve and accelerate your clinical studies and global reach
About This EventAs a global laboratory partner, Q2 Solutions offers the strategic supply chain, global footprint, deep scientific expertise and experience to create, facilitate and continuously support a higher level of lung health-related clinical research worldwide.
Because the challenges you face are unique, we leverage flexible, integrated industry-leading lab technology and thereby, continuously strive to streamline your clinical operations. Q2 Solutions’ seasoned team of scientists and project managers understand the scientific and medical challenges of your protocol and can help you reach your goals on time and within budget.
With the world’s largest network of CAP-accredited end-to-end central laboratories, Q2 Solutions brings the consistency that can help power the success of your clinical trials – we support your lung health study through our large, fully customizable validated test menu, harmonized processes with clinical data management for full-service integration, and biomarker discovery and development strategy to support latest precision medicine developments in the battle against lung cancer.
Schedule a meeting with us at this year’s Union World Conference on Lung Health to learn how we can partner with you to make the study process a collaborative and seamless effort as well as an intelligent one, and in doing so - improving human health through innovation globally.
We look forward to meeting you in The Hague.